CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 1,750 shares (grant or award)
- 4 Open-market buy Director bought 948,353 shares at $19.24 ($18,246,312)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000,000 shares at an average $16.65 ($83,251,536)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 95,489 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 624 shares (to pay taxes)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Grant or award Director acquired 11,037 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 624 shares (to pay taxes)
- 4 Grant or award Director acquired 443 shares (grant or award)
- 4 Grant or award Director acquired 2,419 shares (grant or award)
- 4 Grant or award Director acquired 1,774 shares (grant or award)
- 4 Grant or award Director acquired 2,016 shares (grant or award)
- 4 Open-market buy Director bought 2,500 shares at $15.54 ($38,838)
Page 18 of 61 · 1,214 filings